STAHL NEIL
Known title: EVP Research and DevelopmentCIK: 0001226689
Associated companies
Transaction History
| REGN | ▼ Sell | Tax Withholding | 304 | $222K | 12/16/2024 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 466 | $367K | 12/9/2024 | View on chart |
| REGN | ▼ Sell | Gift | 500 | $0 | 8/13/2024 | View on chart |
| REGN | ▼ Sell | Gift | 900 | $0 | 8/12/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,883 | $2.0M | 8/8/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,708 | $1.9M | 8/8/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,006 | $1.1M | 8/8/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 300 | $326K | 8/8/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $108K | 8/8/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 200 | $217K | 8/8/2024 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 18,441 | $20.2M | 8/2/2024 | View on chart |
| REGN | ▲ Buy | Option Exercise | 23,638 | $13.1M | 8/2/2024 | View on chart |
| REGN | ▼ Sell | Gift | 1,020 | $0 | 2/26/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 19 | $18K | 2/7/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $95K | 2/7/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,894 | $1.8M | 2/7/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 601 | $571K | 2/7/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 3,127 | $3.0M | 2/7/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,237 | $1.2M | 2/7/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,059 | $1.0M | 2/7/2024 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 22,713 | $21.7M | 2/2/2024 | View on chart |
| REGN | ▲ Buy | Option Exercise | 30,750 | $12.3M | 2/2/2024 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 725 | $612K | 12/11/2023 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 809 | $683K | 12/8/2023 | View on chart |
| REGN | ▲ Buy | Grant | 853 | $0 | 12/8/2023 | View on chart |
| REGN | ▼ Sell | Gift | 400 | $0 | 11/10/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 6,309 | $5.3M | 8/22/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 4,574 | $3.8M | 8/22/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 782 | $659K | 8/22/2023 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 38,335 | $31.9M | 8/21/2023 | View on chart |
| REGN | ▲ Buy | Option Exercise | 50,000 | $20.0M | 8/21/2023 | View on chart |
| REGN | ▲ Buy | Grant | 1,101 | $0 | 12/16/2022 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 466 | $351K | 12/9/2022 | View on chart |
| REGN | ▼ Sell | Gift | 330 | $0 | 11/8/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 724 | $440K | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 3,931 | $2.4M | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 2,076 | $1.3M | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 1,610 | $991K | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 535 | $330K | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 502 | $311K | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 177 | $110K | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 100 | $62K | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 3,218 | $2.0M | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 4,112 | $2.5M | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 610 | $371K | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 3,044 | $1.9M | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 424 | $262K | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 2,022 | $1.2M | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 176 | $107K | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 521 | $322K | 8/5/2022 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 71,218 | $43.7M | 8/4/2022 | View on chart |
| REGN | ▲ Buy | Option Exercise | 95,000 | $25.7M | 8/4/2022 | View on chart |
| REGN | ▼ Sell | Gift | 335 | $0 | 2/18/2022 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 753 | $500K | 12/11/2021 | View on chart |
| REGN | ▲ Buy | Grant | 2,926 | $0 | 12/8/2021 | View on chart |
| REGN | ▲ Buy | Option Exercise | 72,500 | $13.0M | 12/3/2021 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 50,352 | $31.8M | 12/3/2021 | View on chart |
| REGN | ▼ Sell | Gift | 4,605 | $0 | 11/29/2021 | View on chart |
| REGN | ▼ Sell | Gift | 4,605 | $0 | 11/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Regeneron Gets EU Approval for Libtayo Dosing, UBS Upgrades Stock
Regeneron received a positive recommendation from the EU's CHMP for an updated Libtayo dosing regimen across all approved cancer types. This regulatory progress follows strong earnings and new Phase III data for a treatment for FOP. UBS recently upgraded the stock to Buy and raised its price target to $978, citing the company's potential value.
Regeneron Gets EU Approval for Libtayo Dosing, UBS Upgrades Stock. Regeneron received a positive recommendation from the EU's CHMP for an updated Libtayo dosing regimen across all approved cancer types. This regulatory progress follows strong earnings and new Phase III data for a treatment for FOP. UBS recently upgraded the stock to Buy and raised its price target to $978, citing the company's potential value.